These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3832073)

  • 1. Role of degradation products of 2-5A in the localized cleavage of viral RNA.
    Baglioni C; Williams GJ
    Prog Clin Biol Res; 1985; 202():275-83. PubMed ID: 3832073
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
    Williams GJ; De Benedetti A; Baglioni C
    Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
    Rice AP; Roberts WK; Kerr IM
    J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.
    Silverman RH; Cayley PJ; Wreschner DH; Knight M; Gilbert CS; Brown RE; Kerr IM
    Tex Rep Biol Med; 1981-1982; 41():479-86. PubMed ID: 6189212
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved.
    Domingo-Gil E; Esteban M
    Apoptosis; 2006 May; 11(5):725-38. PubMed ID: 16532271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruiting the 2-5A system for antisense therapeutics.
    Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell viability and the (2',5')oligo(A)-RNase L pathway in human colon carcinoma cells treated with human interferons and double-stranded RNA.
    Chapekar MS; Glazer RI
    Prog Clin Biol Res; 1985; 202():377-84. PubMed ID: 2421317
    [No Abstract]   [Full Text] [Related]  

  • 10. Oligonucleotide structural features involved in binding to and activation of the 2-5A-dependent endoribonuclease of L cells.
    Imai J; Lesiak K; Johnston MI; Torrence PF
    Nucleic Acids Symp Ser; 1982; (11):97-100. PubMed ID: 7183979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal antibody directed against 2-5A-dependent RNase.
    Dieffenbach CW; Krause D; Silverman RH
    Prog Clin Biol Res; 1985; 202():105-14. PubMed ID: 2421296
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of 2',5'-oligoadenylate analogs containing an adenine acyclonucleoside and their ability to activate human RNase L.
    Ueno Y; Ishihara S; Ito Y; Kitade Y
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4431-4. PubMed ID: 15357966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
    Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2-5A system and vaccinia virus.
    Esteban M; Paez E
    Prog Clin Biol Res; 1985; 202():25-34. PubMed ID: 2421306
    [No Abstract]   [Full Text] [Related]  

  • 15. Respective role of each of the purine N-6 amino groups of 5'-O-triphosphoryladenylyl(2'----5')adenylyl(2----5')adenosine in binding to and activation of RNase L.
    Imai J; Lesiak K; Torrence PF
    J Biol Chem; 1985 Feb; 260(3):1390-3. PubMed ID: 2981855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine 8-substitution modulates the ribonuclease L binding and activation abilities of 2',5'-oligoadenylates.
    Kanou M; Ohomori H; Nagai K; Yokoyama S; Suhadolnik RJ; Sobol R; Takaku H
    Biochem Biophys Res Commun; 1991 Apr; 176(2):769-74. PubMed ID: 2025289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activities of 8-substituted 2-5A analogues.
    Nagai K; Yokoyama S; Kawai G; Shuhadlnik RJ; Takaku H
    Nucleic Acids Symp Ser; 1990; (22):13-4. PubMed ID: 2101896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral and achiral phosphorothioate analogs of 2-5A: enzymatic synthesis, characterization, and biological activities.
    Suhadolnik RJ; Lee C
    Prog Clin Biol Res; 1985; 202():115-22. PubMed ID: 3832068
    [No Abstract]   [Full Text] [Related]  

  • 20. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.